Supplemental silicon increases plasma and milk silicon concentrations in horses.
The primary objective of this research was to determine the effect of supplemental dietary silicon (Si) on plasma and milk Si concentrations of lactating mares and the subsequent effect on plasma Si concentrations in nursing foals. Additionally, the role of Si on altering biochemical markers of bone turnover was investigated, because supplemental Si may be advantageous in enhancing bone health. Twelve Arabian mare/foal units were pair-matched by foaling date and randomly assigned to two groups, Si-supplemented (Supplemented) or control (Control). Blood and milk samples were taken on d 0, 15, 30, and 45, d 0 being the 1st d after parturition. Plasma and milk (or colostrum) Si concentrations were determined and serum was analyzed for osteocalcin, carboxy-terminal pyridinoline cross-linked telopeptide region of type I collagen, and pyridinoline and deoxypyridinoline crosslinks. All Supplemented mares had higher (P < 0.01) plasma Si concentrations than Control by d 30, and Supplemented mares' milk had higher (P < 0.01) Si concentrations on d 45 than Control mares' milk. By d 45, foals of Supplemented mares had higher (P < 0.01) plasma Si concentrations than foals of Control mares. Supplemental Si did not influence (P > 0.36) bone metabolism in foals; however, trends (P < 0.10) for altered bone metabolism were observed in postpartum mares. Results indicate that supplemental Si increases plasma and milk Si concentrations. Further research is required to determine whether Si has a role in altering serum biochemical markers of bone and collagen activity.
Lang
K J
KJ
Department of Animal Science, Michigan State University, East Lansing 48824, USA.
Nielsen
B D
BD
Waite
K L
KL
Hill
G M
GM
Orth
M W
MW
D000596:Amino Acids / Q000097:blood; D000818:Animals; D000833:Animals, Suckling / Q000033:anatomy & histology / Q000097:blood*; D015415:Biomarkers / Q000032:analysis; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism*; D003094:Collagen / Q000097:blood; D024042:Collagen Type I; D003126:Colostrum / Q000737:chemistry; D005260:Female; D006736:Horses / Q000378:metabolism / Q000502:physiology*; D007774:Lactation / Q000502:physiology; D008892:Milk / Q000737:chemistry*; D015675:Osteocalcin / Q000097:blood; D010455:Peptides / Q000097:blood; D011897:Random Allocation; D012825:Silicon / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism*
D000596:Amino Acids; D015415:Biomarkers; D024042:Collagen Type I; D010455:Peptides; C052929:collagen type I trimeric cross-linked peptide; D015675:Osteocalcin; C015484:pyridinoline; C036020:deoxypyridinoline; D003094:Collagen; D012825:Silicon